SCHEMBL4750642

SCHEMBL4750642

CC(C)(C)c1ccc(N(c2ccc(-c3ccccc3)cc2)c2ccc(-c3nc4ccccc4nc3-c3ccc(N(c4ccc(-c5ccccc5)cc4)c4ccc(C(C)(C)C)cc4)cc3)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.60
AKT2 P31751 1/20 0.60
TDP1 Q9NUW8 2/20 0.51
L3MBTL1 Q9Y468 5/20 0.47
KDM4E B2RXH2 5/20 0.47
LMNA P02545 4/20 0.47
ALDH1A1 P00352 4/20 0.47
NPSR1 Q6W5P4 1/20 0.47
GAA P10253 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
TP53 P04637 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CNR1 P21554 1/20 0.43
CNR2 P34972 1/20 0.43
GPR55 Q9Y2T6 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
TNF P01375 1/20 0.43
NOD1 Q9Y239 1/20 0.43
TNKS O95271 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12690677 0.97 AKT1 (0.56) AKT1AKT2TDP1L3MBTL1KDM4E
SCHEMBL21998534 0.89 AKT1 (0.74) AKT1AKT2TDP1L3MBTL1KDM4E
SCHEMBL10315140 0.88 AKT1 (0.51) AKT1AKT2TDP1L3MBTL1KDM4E
SCHEMBL10315371 0.88 AKT1 (0.51) AKT1AKT2TDP1L3MBTL1KDM4E
SCHEMBL2745128 0.87 KDM4E (0.60) AKT1AKT2TDP1L3MBTL1KDM4E
SCHEMBL12146739 0.87 KDM4E (0.60) AKT1AKT2TDP1L3MBTL1KDM4E
SCHEMBL4750880 0.87 KDM4E (0.60) AKT1AKT2TDP1L3MBTL1KDM4E
SCHEMBL6724233 0.87 KDM4E (0.60) AKT1AKT2TDP1L3MBTL1KDM4E
SCHEMBL4750745 0.87 KDM4E (0.60) AKT1AKT2TDP1L3MBTL1KDM4E
SCHEMBL12146629 0.87 KDM4E (0.60) AKT1AKT2TDP1L3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8623523-B2 Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-01-07 US disclosed
US-8623523-B2 Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-01-07 US disclosed
US-20120211738-A1 Quinoxaline Derivative, and Light Emitting Element, Light Emitting Device, and Electronic Appliance Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-08-23 US disclosed
US-20120211738-A1 Quinoxaline Derivative, and Light Emitting Element, Light Emitting Device, and Electronic Appliance Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-08-23 US disclosed
US-8173277-B2 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic appliance using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-05-08 US disclosed
US-8173277-B2 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic appliance using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-05-08 US disclosed
US-20110186825-A1 Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Appliance Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2011-08-04 US disclosed
US-20110186825-A1 Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Appliance Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2011-08-04 US disclosed
US-7901792-B2 Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-03-08 US disclosed
US-7901792-B2 Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-03-08 US disclosed
WO-2007032258-A1 QUINOXALINE DERIVATIVE, AND LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC APPLIANCE USING THE SAME SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-03-22 WO disclosed
US-20070059553-A1 Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2007-03-15 US disclosed
US-20070059553-A1 Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070059553-A1 Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same CRY1, CRY2, ARL1 AKT1 3674/4885AKT2 3408/4885TDP1 2672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.